Need help finding what you are looking for?
Contact Us
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1236108
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1236108
Global Urinary Tract Infection Therapeutics Market Size study & Forecast, by Drug, by Indication, and Regional Analysis, 2022-2029
PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global Urinary Tract Infection Therapeutics Market is valued at approximately USD 8.66 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3 % over the forecast period 2022-2029. Urinary Tract Infection is one of the most common bacterial infections that occur majorly in women as compared to men. It affects the urinary tract. The Urinary Tract Infection Therapeutics market is expanding because of factors such as the rising growing prevalence of kidney stones and diabetes and the launch of combination drugs.
According to the World Health Organization 2019, diabetes claimed the lives of approximately 1.5 million people worldwide, Diabetes currently affects 537 million people worldwide, according to estimates. Projections show that by 2045, there will be 783 million diabetics worldwide. Whereas the rising geriatric population and growing R&D activities by market players create lucrative opportunities for the market. However, lack of awareness in developing countries hampers market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Urinary Tract Infection Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing prevalence of kidney stones, and diabetes. , Also, North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing awareness towards UTIs, growing spending towards personal care, and growth activities by market players in the forecast period.
Major market players included in this report are:
- AstraZeneca
- Bayer AG
- Cipla Inc.
- GlaxoSmithKline PLC
- Shionogi & Co. Ltd
- Novartis AG
- Pfizer
- Merck & Co. Inc
- Bristol-Myers Squibb Company
- Almirall SA
Recent Developments in the Market:
- In October 2021, Spero Therapeutics Inc. submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tebipenem HBr tablets for the treatment of complicated urinary tract infections (cUTI) caused by susceptible microorganisms, including pyelonephritis.
- In September 2021, Biapenem was introduced by BDR Pharma, one of India's leading generic pharmaceutical companies, to treat patients with intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections.
Global Urinary Tract Infection Therapeutics Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Drug, Indication, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug:
- Penicillin and Combinations
- Quinolones
- Cephalosporin
- Azoles and Amphotericin B
- Nitrofurans
- Other Drugs
By Indication:
- Complicated UTI
- Uncomplicated UTI
- Other Indications
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Urinary Tract Infection Therapeutics Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Urinary Tract Infection Therapeutics Market, by Drug, 2019-2029 (USD Billion)
- 1.2.3. Urinary Tract Infection Therapeutics Market, by Indication, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Urinary Tract Infection Therapeutics Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Urinary Tract Infection Therapeutics Market Dynamics
- 3.1. Urinary Tract Infection Therapeutics Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Growing prevalence of kidney stones and diabetes
- 3.1.1.2. Launch of combination drugs
- 3.1.2. Market Challenges
- 3.1.2.1. Lack of awareness in developing countries
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising geriatric population
- 3.1.3.2. Growing R&D activities by market players
- 3.1.1. Market Drivers
Chapter 4. Global Urinary Tract Infection Therapeutics Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Urinary Tract Infection Therapeutics Market, by Drug
- 6.1. Market Snapshot
- 6.2. Global Urinary Tract Infection Therapeutics Market by Drug, Performance - Potential Analysis
- 6.3. Global Urinary Tract Infection Therapeutics Market Estimates & Forecasts by Drug 2019-2029 (USD Billion)
- 6.4. Urinary Tract Infection Therapeutics Market, Sub-Segment Analysis
- 6.4.1. Penicillin and Combinations
- 6.4.2. Quinolones
- 6.4.3. Cephalosporin
- 6.4.4. Azoles and Amphotericin B
- 6.4.5. Nitrofurans
- 6.4.6. Other Drugs Global Urinary Tract Infection Therapeutics Market, by Indication Market Snapshot
- 6.5. Global Urinary Tract Infection Therapeutics Market by Indication, Performance - Potential Analysis
- 6.6. Global Urinary Tract Infection Therapeutics Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
- 6.7. Urinary Tract Infection Therapeutics Market, Sub Segment Analysis
- 6.7.1. Complicated UTI
- 6.7.2. Uncomplicated UTI
- 6.7.3. Other Indications
Chapter 7. Global Urinary Tract Infection Therapeutics Market, Regional Analysis
- 7.1. Urinary Tract Infection Therapeutics Market, Regional Market Snapshot
- 7.2. North America Urinary Tract Infection Therapeutics Market
- 7.2.1. U.S. Urinary Tract Infection Therapeutics Market
- 7.2.1.1. Drug breakdown estimates & forecasts, 2019-2029
- 7.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
- 7.2.2. Canada Urinary Tract Infection Therapeutics Market
- 7.2.1. U.S. Urinary Tract Infection Therapeutics Market
- 7.3. Europe Urinary Tract Infection Therapeutics Market Snapshot
- 7.3.1. U.K. Urinary Tract Infection Therapeutics Market
- 7.3.2. Germany Urinary Tract Infection Therapeutics Market
- 7.3.3. France Urinary Tract Infection Therapeutics Market
- 7.3.4. Spain Urinary Tract Infection Therapeutics Market
- 7.3.5. Italy Urinary Tract Infection Therapeutics Market
- 7.3.6. Rest of Europe Urinary Tract Infection Therapeutics Market
- 7.4. Asia-Pacific Urinary Tract Infection Therapeutics Market Snapshot
- 7.4.1. China Urinary Tract Infection Therapeutics Market
- 7.4.2. India Urinary Tract Infection Therapeutics Market
- 7.4.3. Japan Urinary Tract Infection Therapeutics Market
- 7.4.4. Australia Urinary Tract Infection Therapeutics Market
- 7.4.5. South Korea Urinary Tract Infection Therapeutics Market
- 7.4.6. Rest of Asia Pacific Urinary Tract Infection Therapeutics Market
- 7.5. Latin America Urinary Tract Infection Therapeutics Market Snapshot
- 7.5.1. Brazil Urinary Tract Infection Therapeutics Market
- 7.5.2. Mexico Urinary Tract Infection Therapeutics Market
- 7.5.3. Rest of Latin America Urinary Tract Infection Therapeutics Market
- 7.6. Rest of The World Urinary Tract Infection Therapeutics Market
Chapter 8. Competitive Intelligence
- 8.1. Top Market Strategies
- 8.2. Company Profiles
- 8.2.1. AstraZeneca
- 8.2.1.1. Key Information
- 8.2.1.2. Overview
- 8.2.1.3. Financial (Subject to Data Availability)
- 8.2.1.4. Product Summary
- 8.2.1.5. Recent Developments
- 8.2.2. Bayer AG
- 8.2.3. Cipla Inc.
- 8.2.4. GlaxoSmithKline PLC
- 8.2.5. Shionogi & Co. Ltd
- 8.2.6. Novartis AG
- 8.2.7. Pfizer
- 8.2.8. Merck & Co. Inc
- 8.2.9. Bristol-Myers Squibb Company
- 8.2.10. Almirall SA
- 8.2.1. AstraZeneca
Chapter 9. Research Process
- 9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
- 9.2. Research Attributes
- 9.3. Research Assumption
LIST OF TABLES
- TABLE 1. Global Urinary Tract Infection Therapeutics Market, report scope
- TABLE 2. Global Urinary Tract Infection Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
- TABLE 3. Global Urinary Tract Infection Therapeutics Market estimates & forecasts by Drug 2019-2029 (USD Billion)
- TABLE 4. Global Urinary Tract Infection Therapeutics Market estimates & forecasts by Indication 2019-2029 (USD Billion)
- TABLE 5. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 6. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 7. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 8. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 9. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 10. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 11. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 12. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 13. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 14. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 15. U.S. Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 16. U.S. Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 17. U.S. Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 18. Canada Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 19. Canada Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 20. Canada Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 21. UK Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 22. UK Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 23. UK Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 24. Germany Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 25. Germany Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 26. Germany Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 27. France Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 28. France Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 29. France Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 30. Italy Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 31. Italy Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 32. Italy Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 33. Spain Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 34. Spain Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 35. Spain Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 36. RoE Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 37. RoE Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 38. RoE Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 39. China Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 40. China Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 41. China Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 42. India Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 43. India Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 44. India Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 45. Japan Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 46. Japan Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 47. Japan Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 48. South Korea Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 49. South Korea Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 50. South Korea Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 51. Australia Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 52. Australia Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 53. Australia Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 54. RoAPAC Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 55. RoAPAC Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 56. RoAPAC Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 57. Brazil Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 58. Brazil Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 59. Brazil Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 60. Mexico Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 61. Mexico Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 62. Mexico Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 63. RoLA Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 64. RoLA Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 65. RoLA Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 66. Row Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
- TABLE 67. Row Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 68. Row Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
- TABLE 69. List of secondary sources, used in the study of global Urinary Tract Infection Therapeutics Market
- TABLE 70. List of primary sources, used in the study of global Urinary Tract Infection Therapeutics Market
- TABLE 71. Years considered for the study
- TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
List of figures
- FIG 1. Global Urinary Tract Infection Therapeutics Market, research methodology
- FIG 2. Global Urinary Tract Infection Therapeutics Market, Market estimation techniques
- FIG 3. Global Market size estimates & forecast methods
- FIG 4. Global Urinary Tract Infection Therapeutics Market, key trends 2021
- FIG 5. Global Urinary Tract Infection Therapeutics Market, growth prospects 2022-2029
- FIG 6. Global Urinary Tract Infection Therapeutics Market, porters 5 force model
- FIG 7. Global Urinary Tract Infection Therapeutics Market, pest analysis
- FIG 8. Global Urinary Tract Infection Therapeutics Market, value chain analysis
- FIG 9. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
- FIG 10. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
- FIG 11. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
- FIG 12. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
- FIG 13. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
- FIG 14. Global Urinary Tract Infection Therapeutics Market, regional snapshot 2019 & 2029
- FIG 15. North America Urinary Tract Infection Therapeutics Market 2019 & 2029 (USD Billion)
- FIG 16. Europe Urinary Tract Infection Therapeutics Market 2019 & 2029 (USD Billion)
- FIG 17. Asia Pacific Urinary Tract Infection Therapeutics Market 2019 & 2029 (USD Billion)
- FIG 18. Latin America Urinary Tract Infection Therapeutics Market 2019 & 2029 (USD Billion)
- FIG 19. Global Urinary Tract Infection Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.